Symbols / LITS Stock $1.18 -5.60% Lite Strategy, Inc.
LITS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Ratings
- Lite Strategy (Nasdaq: LITS) ramps up LTC yield strategy and $25M buyback plan - Stock Titan Wed, 13 May 2026 12
- Lite Strategy (LITS) Q3 FY2026 Earnings: EPS N/A, Revenue N/A -- - GuruFocus Wed, 13 May 2026 13
- symbol__ Stock Quote Price and Forecast - CNN Fri, 12 Sep 2025 17
- Top Lite Strategy (LITS) Competitors 2026 - MarketBeat Wed, 13 May 2026 02
- Is Lite Strategy (NASDAQ:LITS) In A Good Position To Invest In Growth? - Yahoo Finance Sat, 25 Apr 2026 07
- MSN Money - MSN Sat, 09 May 2026 15
- Lite Strategy Reports Fiscal 2026 Third Quarter Results - marketscreener.com Wed, 13 May 2026 12
- LITS Stock Price and Chart — NASDAQ:LITS - TradingView Sat, 04 Oct 2025 07
- Have Lite Strategy Insiders Been Selling Stock? - simplywall.st Wed, 24 Dec 2025 08
- What is the current Price Target and Forecast for Lite Strategy, Inc. (LITS) - Zacks Investment Research Sun, 23 Nov 2025 06
- Lite Strategy: From Biotech To Litecoin Treasury (NASDAQ:LITS) - Seeking Alpha ue, 16 Sep 2025 07
- Why Tilray Stock Lit Up Today - The Motley Fool Fri, 12 Dec 2025 08
- MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ - Business Wire Wed, 10 Sep 2025 07
- 10 Stocks the Best Fund Managers Have Been Buying in 2025 - Morningstar hu, 04 Dec 2025 08
- Lite Strategy stock surges after announcing $25 million share buyback - Investing.com Wed, 29 Oct 2025 07
Insider Transactions
Financials
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
65.30
+33.76%
|
48.82
+19.95%
|
40.70
|
| Operating Revenue |
|
0.00
-100.00%
|
65.30
+33.76%
|
48.82
+19.95%
|
40.70
|
| Cost Of Revenue |
|
—
|
—
|
—
|
0.00
|
| Reconciled Cost Of Revenue |
|
—
|
—
|
—
|
0.00
|
| Gross Profit |
|
—
|
—
|
—
|
40.70
|
| Operating Expense |
|
17.45
-56.20%
|
39.86
-53.43%
|
85.58
-26.34%
|
116.18
|
| Research And Development |
|
3.92
-76.31%
|
16.56
-68.43%
|
52.45
-38.76%
|
85.64
|
| Selling General And Administration |
|
13.53
-41.91%
|
23.30
-29.69%
|
33.13
+8.48%
|
30.54
|
| General And Administrative Expense |
|
13.53
-41.91%
|
23.30
-29.69%
|
33.13
+8.48%
|
30.54
|
| Other Gand A |
|
13.53
-41.91%
|
23.30
-29.69%
|
33.13
+8.48%
|
30.54
|
| Total Expenses |
|
17.45
-56.20%
|
39.86
-53.43%
|
85.58
-26.34%
|
116.18
|
| Operating Income |
|
-17.45
-168.61%
|
25.44
+169.20%
|
-36.76
+51.30%
|
-75.48
|
| Total Operating Income As Reported |
|
-17.45
-220.03%
|
14.54
+139.55%
|
-36.76
+51.30%
|
-75.48
|
| EBITDA |
|
-17.09
-166.17%
|
25.82
+170.99%
|
-36.38
+51.60%
|
-75.16
|
| Normalized EBITDA |
|
-17.59
-147.89%
|
36.72
+196.69%
|
-37.98
+60.40%
|
-95.91
|
| Reconciled Depreciation |
|
0.37
-3.92%
|
0.38
-0.78%
|
0.39
+18.40%
|
0.33
|
| EBIT |
|
-17.45
-168.61%
|
25.44
+169.20%
|
-36.76
+51.30%
|
-75.48
|
| Total Unusual Items |
|
0.50
+104.59%
|
-10.90
-779.91%
|
1.60
-92.28%
|
20.75
|
| Total Unusual Items Excluding Goodwill |
|
0.50
+104.59%
|
-10.90
-779.91%
|
1.60
-92.28%
|
20.75
|
| Special Income Charges |
|
0.50
+104.59%
|
-10.90
|
0.00
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
10.90
|
0.00
|
—
|
| Net Income |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Pretax Income |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Net Non Operating Interest Income Expense |
|
1.03
-68.69%
|
3.28
-2.03%
|
3.35
+1077.82%
|
0.28
|
| Net Interest Income |
|
1.03
-68.69%
|
3.28
-2.03%
|
3.35
+1077.82%
|
0.28
|
| Interest Income Non Operating |
|
1.03
-68.69%
|
3.28
-2.03%
|
3.35
+1077.82%
|
0.28
|
| Interest Income |
|
1.03
-68.69%
|
3.28
-2.03%
|
3.35
+1077.82%
|
0.28
|
| Other Income Expense |
|
0.48
+104.42%
|
-10.94
-791.97%
|
1.58
-92.38%
|
20.75
|
| Other Non Operating Income Expenses |
|
-0.02
+60.98%
|
-0.04
-86.36%
|
-0.02
-266.67%
|
-0.01
|
| Gain On Sale Of Security |
|
—
|
—
|
1.60
-92.28%
|
20.75
|
| Tax Provision |
|
—
|
—
|
—
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+100.00%
|
-2.29
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Net Income From Continuing Operation Net Minority Interest |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Net Income From Continuing And Discontinued Operation |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Net Income Continuous Operations |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Normalized Income |
|
-16.45
-162.32%
|
26.39
+178.91%
|
-33.44
+55.53%
|
-75.21
|
| Net Income Common Stockholders |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Diluted EPS |
|
-2.39
-189.51%
|
2.67
+155.86%
|
-4.78
+52.15%
|
-9.99
|
| Basic EPS |
|
-2.39
-189.51%
|
2.67
+155.86%
|
-4.78
+45.37%
|
-8.75
|
| Basic Average Shares |
|
6.66
+0.00%
|
6.66
+0.00%
|
6.66
+7.05%
|
6.22
|
| Diluted Average Shares |
|
6.66
+0.00%
|
6.66
+0.00%
|
6.66
+6.49%
|
6.26
|
| Diluted NI Availto Com Stockholders |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+49.06%
|
-62.50
|
| Average Dilution Earnings |
|
—
|
—
|
0.00
+100.00%
|
-8.05
|
| Gain On Sale Of PPE |
|
0.50
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
18.29
-55.81%
|
41.38
-65.75%
|
120.81
-32.07%
|
177.84
|
| Current Assets |
|
18.29
-55.15%
|
40.77
-62.09%
|
107.53
-35.66%
|
167.13
|
| Cash Cash Equivalents And Short Term Investments |
|
18.01
-53.03%
|
38.34
-61.92%
|
100.69
-34.30%
|
153.25
|
| Cash And Cash Equivalents |
|
18.01
+386.13%
|
3.71
-78.08%
|
16.91
+7.41%
|
15.74
|
| Other Short Term Investments |
|
0.00
-100.00%
|
34.64
-58.66%
|
83.79
-39.07%
|
137.51
|
| Receivables |
|
—
|
0.00
-100.00%
|
0.09
-99.15%
|
10.04
|
| Accounts Receivable |
|
—
|
—
|
0.00
|
0.00
|
| Other Receivables |
|
—
|
—
|
0.09
-99.15%
|
10.04
|
| Taxes Receivable |
|
—
|
—
|
—
|
—
|
| Prepaid Assets |
|
0.00
-100.00%
|
1.05
-77.17%
|
4.60
+20.08%
|
3.83
|
| Other Current Assets |
|
0.27
-80.06%
|
1.37
-36.12%
|
2.15
-43.84%
|
3.83
|
| Total Non Current Assets |
|
0.00
-100.00%
|
0.61
-95.44%
|
13.28
+23.96%
|
10.71
|
| Net PPE |
|
0.00
-100.00%
|
0.61
-95.44%
|
13.28
+23.96%
|
10.71
|
| Gross PPE |
|
0.00
-100.00%
|
2.37
-83.44%
|
14.31
+25.99%
|
11.36
|
| Accumulated Depreciation |
|
—
|
-1.76
-70.60%
|
-1.03
-59.57%
|
-0.65
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.00
-100.00%
|
0.21
-98.21%
|
11.97
+32.23%
|
9.05
|
| Machinery Furniture Equipment |
|
—
|
1.00
+0.00%
|
1.00
-20.26%
|
1.25
|
| Other Properties |
|
—
|
0.19
-50.00%
|
0.37
-95.87%
|
9.05
|
| Leases |
|
—
|
0.97
+0.00%
|
0.97
-8.06%
|
1.05
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
1.35
-83.79%
|
8.36
-91.31%
|
96.19
-23.31%
|
125.43
|
| Current Liabilities |
|
1.35
-83.79%
|
8.36
-58.92%
|
20.34
-16.79%
|
24.44
|
| Payables And Accrued Expenses |
|
0.48
-91.31%
|
5.53
-51.48%
|
11.41
-20.75%
|
14.39
|
| Payables |
|
0.18
-94.44%
|
3.17
-48.35%
|
6.13
-22.53%
|
7.92
|
| Accounts Payable |
|
0.18
-94.44%
|
3.17
-48.35%
|
6.13
-22.53%
|
7.92
|
| Current Accrued Expenses |
|
0.30
-87.11%
|
2.37
-55.12%
|
5.27
-18.57%
|
6.47
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.87
-69.05%
|
2.82
-60.76%
|
7.19
+65.42%
|
4.35
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
1.43
+63.95%
|
0.87
|
| Current Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
1.43
+63.95%
|
0.87
|
| Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
0.32
-93.44%
|
4.83
|
| Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
0.32
-93.44%
|
4.83
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
0.00
-100.00%
|
75.84
-24.89%
|
100.98
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
11.30
+28.83%
|
8.77
|
| Long Term Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
11.30
+28.83%
|
8.77
|
| Non Current Deferred Liabilities |
|
—
|
0.00
-100.00%
|
64.55
-28.77%
|
90.61
|
| Non Current Deferred Revenue |
|
—
|
0.00
-100.00%
|
64.55
-28.77%
|
90.61
|
| Stockholders Equity |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Common Stock Equity |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
6.66
+0.00%
|
6.66
0.00%
|
6.66
+0.08%
|
6.66
|
| Ordinary Shares Number |
|
6.66
+0.00%
|
6.66
0.00%
|
6.66
+0.08%
|
6.66
|
| Additional Paid In Capital |
|
421.10
-0.03%
|
421.24
-2.18%
|
430.62
+0.95%
|
426.57
|
| Retained Earnings |
|
-404.16
-4.11%
|
-388.22
+4.38%
|
-406.00
-8.51%
|
-374.16
|
| Total Equity Gross Minority Interest |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Total Capitalization |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Working Capital |
|
16.93
-47.77%
|
32.41
-62.82%
|
87.19
-38.89%
|
142.68
|
| Invested Capital |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Total Debt |
|
—
|
0.00
-100.00%
|
12.73
+32.01%
|
9.64
|
| Capital Lease Obligations |
|
—
|
0.00
-100.00%
|
12.73
+32.01%
|
9.64
|
| Net Tangible Assets |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Tangible Book Value |
|
16.93
-48.73%
|
33.02
+34.10%
|
24.62
-53.02%
|
52.41
|
| Derivative Product Liabilities |
|
—
|
—
|
0.00
-100.00%
|
1.60
|
| Preferred Shares Number |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-20.84
+58.70%
|
-50.47
+3.83%
|
-52.48
-7.67%
|
-48.75
|
| Cash Flow From Continuing Operating Activities |
|
-20.84
+58.70%
|
-50.47
+3.83%
|
-52.48
-7.67%
|
-48.75
|
| Net Income From Continuing Operations |
|
-15.95
-189.69%
|
17.78
+155.84%
|
-31.84
+41.53%
|
-54.45
|
| Depreciation Amortization Depletion |
|
0.37
-3.92%
|
0.38
-0.78%
|
0.39
+18.40%
|
0.33
|
| Depreciation |
|
0.37
-3.92%
|
0.38
-0.78%
|
0.39
+18.40%
|
0.33
|
| Depreciation And Amortization |
|
0.37
-3.92%
|
0.38
-0.78%
|
0.39
+18.40%
|
0.33
|
| Other Non Cash Items |
|
0.21
-91.20%
|
2.43
+70.26%
|
1.43
+57.21%
|
0.91
|
| Stock Based Compensation |
|
-0.14
-106.32%
|
2.28
-36.53%
|
3.59
-57.02%
|
8.35
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
10.90
|
0.00
|
0.00
|
| Operating Gains Losses |
|
-0.49
-1618.75%
|
0.03
+102.90%
|
-1.10
+94.68%
|
-20.75
|
| Gain Loss On Investment Securities |
|
-0.50
|
—
|
-1.10
+94.68%
|
-20.75
|
| Gain Loss On Sale Of PPE |
|
0.01
-56.25%
|
0.03
|
0.00
|
—
|
| Change In Working Capital |
|
-4.85
+94.24%
|
-84.28
-237.82%
|
-24.95
-247.83%
|
16.88
|
| Change In Receivables |
|
0.00
-100.00%
|
0.09
-99.15%
|
9.96
+504.51%
|
-2.46
|
| Change In Prepaid Assets |
|
2.15
-52.58%
|
4.53
+255.27%
|
-2.92
-13804.76%
|
-0.02
|
| Change In Payables And Accrued Expense |
|
-7.00
+32.82%
|
-10.42
-7187.41%
|
-0.14
-103.59%
|
3.98
|
| Change In Accrued Expense |
|
-4.01
+44.89%
|
-7.27
-543.27%
|
1.64
-32.13%
|
2.42
|
| Change In Payable |
|
-2.99
+4.93%
|
-3.15
-76.40%
|
-1.78
-214.14%
|
1.56
|
| Change In Account Payable |
|
-2.99
+4.93%
|
-3.15
-76.40%
|
-1.78
-214.14%
|
1.56
|
| Change In Other Working Capital |
|
—
|
-64.86
-112.09%
|
-30.58
-288.52%
|
16.22
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-13.61
-979.46%
|
-1.26
-49.23%
|
-0.84
|
| Investing Cash Flow |
|
35.15
-28.47%
|
49.14
-8.47%
|
53.69
+679.02%
|
6.89
|
| Cash Flow From Continuing Investing Activities |
|
35.15
-28.47%
|
49.14
-8.47%
|
53.69
+679.02%
|
6.89
|
| Net PPE Purchase And Sale |
|
0.01
+242.86%
|
-0.01
+80.00%
|
-0.04
+92.69%
|
-0.48
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.01
+80.00%
|
-0.04
+92.69%
|
-0.48
|
| Sale Of PPE |
|
0.01
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
—
|
-0.01
+80.00%
|
-0.04
+92.69%
|
-0.48
|
| Net Investment Purchase And Sale |
|
35.14
-28.50%
|
49.15
-8.52%
|
53.73
+628.87%
|
7.37
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-58.23
+42.78%
|
-101.76
+62.68%
|
-272.65
|
| Sale Of Investment |
|
35.14
-67.27%
|
107.38
-30.94%
|
155.49
-44.47%
|
280.02
|
| Financing Cash Flow |
|
0.00
+100.00%
|
-11.87
-29570.00%
|
-0.04
-100.08%
|
49.05
|
| Cash Flow From Continuing Financing Activities |
|
0.00
+100.00%
|
-11.87
-29570.00%
|
-0.04
-100.08%
|
49.05
|
| Net Common Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
52.33
|
| Common Stock Dividend Paid |
|
0.00
+100.00%
|
-11.66
|
0.00
|
—
|
| Cash Dividends Paid |
|
0.00
+100.00%
|
-11.66
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
-100.00%
|
0.57
|
| Net Other Financing Charges |
|
—
|
-0.21
-420.00%
|
-0.04
+98.96%
|
-3.85
|
| Changes In Cash |
|
14.31
+208.37%
|
-13.20
-1232.16%
|
1.17
-83.80%
|
7.20
|
| Beginning Cash Position |
|
3.71
-78.08%
|
16.91
+7.41%
|
15.74
+84.24%
|
8.54
|
| End Cash Position |
|
18.01
+386.13%
|
3.71
-78.08%
|
16.91
+7.41%
|
15.74
|
| Free Cash Flow |
|
-20.84
+58.71%
|
-50.48
+3.88%
|
-52.52
-6.69%
|
-49.23
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
—
|
0.00
|
| Common Stock Issuance |
|
—
|
—
|
0.00
-100.00%
|
52.33
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
-100.00%
|
52.33
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-05-13 View
- 10-Q2026-05-13 View
- 8-K2026-02-17 View
- 10-Q2026-02-17 View
- 42026-02-12 View
- 8-K2026-02-12 View
- 8-K2025-12-30 View
- 42025-12-22 View
- 42025-12-22 View
- 8-K2025-12-05 View
- 42025-11-20 View
- 42025-11-19 View
- 42025-11-18 View
- 42025-11-18 View
- 42025-11-18 View
- 42025-11-18 View
- 8-K2025-11-18 View
- 10-Q2025-11-14 View
- 8-K2025-10-30 View
- 42025-10-06 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|